Document is current
Any future updates will be listed below
-
Authors
Styczynski, Jan https://orcid.org/0000-0002-3158-119X
Tridello, Gloria
Knelange, Nina
Wendel, Lotus
Ljungman, Per https://orcid.org/0000-0002-8281-3245
Mikulska, Malgorzata https://orcid.org/0000-0002-5535-4602
Gil, Lidia
Cesaro, Simone https://orcid.org/0000-0002-8698-9547
Averbuch, Diana https://orcid.org/0000-0001-9614-7274
von dem Borne, Peter https://orcid.org/0000-0002-7470-7346
Xhaard, Aliénor https://orcid.org/0000-0002-4449-989X
Mielke, Stephan
Neven, Benedicte
Snowden, John A. https://orcid.org/0000-0001-6819-3476
Dalle, Jean-Hugues
Rubio, Marie Thérèse
Crawley, Charles
Maertens, Johan
Kuball, Jurgen https://orcid.org/0000-0002-3914-7806
Chevallier, Patrice https://orcid.org/0000-0003-3142-5581
Michel, Gérard https://orcid.org/0000-0002-0018-5709
Gabriel, Melissa
Burns, David
Wynn, Robert F. https://orcid.org/0000-0002-6046-8428
Renard, Cecile
Blijlevens, Nicole
Jubert, Charlotte
Gedde-Dahl, Tobias
Collin, Matthew
Labussiere-Wallet, Helene
Kalwak, Krzysztof https://orcid.org/0000-0003-1174-5799
Broers, Annoek E. C.
Yakoub-Agha, Ibrahim https://orcid.org/0000-0003-4524-8782
Itäla-Remes, Maija
de la Camara, Rafael https://orcid.org/0000-0002-8189-5779
- License Information
-
More Information
Article History
Received: 9 January 2024
Revised: 24 June 2024
Accepted: 27 June 2024
First Online: 10 July 2024
Competing interests
: MM reports lecture fees and board meeting fees from Allovir, bioMérieux, Gilead, Janssen, Moderna, Mundipharma, Pfizer, all outside the submitted work. JAS declares consultancy for Medac, Jazz, Vertex, and Kiadis Pharma in previous 24 months. All other authors declared no conflict of interest.
: The study was conducted in accordance with the EBMT Guidelines for Retrospective Studies and the principles of the Declaration of Helsinki. EBMT centres commit to obtain informed consent with the local regulations applicable at the time of transplantation in order to report pseudoanonymised data to the EBMT.
